Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion
暂无分享,去创建一个
J. Tajti | L. Edvinsson | A. Csáti | K. Warfvinge | B. Tuka | A. Kuris | Lars Edvinsson | Bernadett Tuka | Anikó Kuris
[1] J. Olesen,et al. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat. , 2011, European journal of pharmacology.
[2] J. Olesen,et al. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery , 2011, Cephalalgia : an international journal of headache.
[3] D. Hay,et al. Regulation of signal transduction by calcitonin gene-related peptide receptors. , 2010, Trends in pharmacological sciences.
[4] P. Goadsby,et al. CGRP and its receptors provide new insights into migraine pathophysiology , 2010, Nature Reviews Neurology.
[5] M. Hanani. Satellite glial cells in sympathetic and parasympathetic ganglia: In search of function , 2010, Brain Research Reviews.
[6] J. Olesen,et al. The PACAP receptor: A novel target for migraine treatment , 2010, Neurotherapeutics.
[7] K. B. Ploug,et al. The in vivo Effect of VIP, PACAP-38 and PACAP-27 and mRNA Expression of Their Receptors in Rat Middle Meningeal Artery , 2009, Cephalalgia : an international journal of headache.
[8] A. Rezai,et al. Acute Treatment of Intractable Migraine With Sphenopalatine Ganglion Electrical Stimulation , 2009, Headache.
[9] P. Goadsby,et al. Neurobiology of migraine , 2009, Neuroscience.
[10] K. Finlayson,et al. VPAC and PAC receptors: From ligands to function. , 2009, Pharmacology & therapeutics.
[11] J. Olesen,et al. Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine , 2008, Cephalalgia : an international journal of headache.
[12] J. Olesen,et al. The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers , 2007, Regulatory Peptides.
[13] J. Olesen,et al. The Headache-Inducing Effect of Cilostazol in Human Volunteers , 2006, Cephalalgia : an international journal of headache.
[14] J. Mcculloch,et al. A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology , 2006, Neuropharmacology.
[15] J. Olesen,et al. Vasoactive Intestinal Polypeptide Evokes Only a Minimal Headache in Healthy Volunteers , 2006, Cephalalgia : an international journal of headache.
[16] R. Burstein,et al. Unitary hypothesis for multiple triggers of the pain and strain of migraine , 2005, The Journal of comparative neurology.
[17] L. Edvinsson,et al. Neurobiology in primary headaches , 2005, Brain Research Reviews.
[18] J. Olesen,et al. The Phosphodiesterase 3 Inhibitor Cilostazol Dilates Large Cerebral Arteries in Humans without Affecting Regional Cerebral Blood Flow , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[19] L. Edvinsson,et al. Peptidergic and non-peptidergic innervation and vasomotor responses of human lenticulostriate and posterior cerebral arteries , 2004, Peptides.
[20] D. Yarnitsky,et al. 2003 Wolff Award: Possible Parasympathetic Contributions to Peripheral and Central Sensitization During Migraine , 2003, Headache.
[21] S. Silberstein. Unilateral Cranial Autonomic Symptoms in Migraine , 2002 .
[22] L. Edvinsson,et al. Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia , 2002, Neuroreport.
[23] J. Tajti,et al. Neuropeptide Expression in the Human Trigeminal Nucleus Caudalis and in the Cervical Spinal Cord C1 and C2 , 2002, Cephalalgia : an international journal of headache.
[24] J. Olesen,et al. Cgrp May Play A Causative Role in Migraine , 2002, Cephalalgia : an international journal of headache.
[25] Andrew K. Dunn,et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model , 2002, Nature Medicine.
[26] N. Suzuki,et al. Origin and co‐localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat , 2001, Microscopy research and technique.
[27] J. Tajti,et al. Messenger molecules and receptor mRNA in the human trigeminal ganglion. , 1999, Journal of the autonomic nervous system.
[28] J. Tajti,et al. Neuronal messengers and peptide receptors in the human sphenopalatine and otic ganglia , 1999, Brain Research.
[29] S. Rawlings,et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. , 1998, Pharmacological reviews.
[30] P. Aubineau,et al. Plasma Protein Extravasation Induced in the Rat Dura Mater by Stimulation of the Parasympathetic Sphenopalatine Ganglion , 1997, Experimental Neurology.
[31] F. Sundler,et al. Pituitary Adenylate Cyclase‐Activating Peptide in Sensory and Autonomic Ganglia: Localization and Regulation a , 1996, Annals of the New York Academy of Sciences.
[32] J. Williams,et al. Modulation of the hyperpolarization‐activated current (Ih) by cyclic nucleotides in guinea‐pig primary afferent neurons. , 1996, The Journal of physiology.
[33] J. Olesen,et al. Cerebral Blood Flow Velocities are Reduced During Attacks of Unilateral Migraine Without Aura , 1995, Cephalalgia : an international journal of headache.
[34] X. Hua,et al. Characterization of muscarinic receptors involved in tracheal CGRP release , 1994, NeuroReport.
[35] H. Kimura,et al. Projections of nitric oxide synthase-containing fibers from the sphenopalatine ganglion to cerebral arteries in the rat , 1994, Neuroscience.
[36] P. Goadsby,et al. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. , 1994, Brain : a journal of neurology.
[37] P. Reeh,et al. Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro , 1993 .
[38] H. Hara,et al. Parasympathetic cerebrovascular innervation: an anterograde tracing from the sphenopalatine ganglion in the rat. , 1993, Neurosurgery.
[39] P. Goadsby,et al. PACAP, a VIP-like Peptide: Immunohistochemical Localization and Effect upon Cat Pial Arteries and Cerebral Blood Flow , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] S. Snyder,et al. Possible Origins and Distribution of Immunoreactive Nitric Oxide Synthase-Containing Nerve Fibers in Cerebral Arteries , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[41] P. Goadsby,et al. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache , 1990, Annals of neurology.
[42] P. Goadsby,et al. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides , 1990, Neuropeptides.
[43] M. Culler,et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.
[44] L. Edvinsson,et al. Journal of Cerebral Blood Flow and Metabolism Retrograde Tracing of Nerve Fibers to the Rat Middle Cerebral Artery with True Blue: Colocalization with Different Peptides , 2022 .
[45] C. Owman,et al. Origins and Pathways of Cerebrovascular Vasoactive Intestinal Polypeptide-Positive Nerves in Rat , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] B. Weir,et al. Pathway of nerves with vasoactive intestinal polypeptide-like immunoreactivity to the major cerebral arteries of the rat , 1988, Cell and Tissue Research.
[47] I. Berezin,et al. Vasoactive intestinal polypeptide-like substance: the potential transmitter for cerebral vasodilation. , 1984, Science.
[48] S. Said. Vasoactive intestinal polypeptide (VIP): Current status , 1984, Peptides.
[49] L. Edvinsson,et al. Adrenergic, Cholinergic and Peptidergic Nerve Fibres in Dura Mater Involvement in Headache? , 1981, Cephalalgia : an international journal of headache.
[50] A. Björklund,et al. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain , 1979, Neuroscience.
[51] V. Mutt,et al. Potent Peripheral and Splanchnic Vasodilator Peptide from Normal Gut , 1970, Nature.
[52] J. Olesen,et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. , 2009, Brain : a journal of neurology.
[53] H. Vaudry,et al. VIP, PACAP, and related peptides: from gene to therapy. Proceedings of the 7th International Symposium on VIP, PACAP, and Related Peptides. September 11-14, 2005. Rouen, France. , 2006, Annals of the New York Academy of Sciences.
[54] D. Tanelian. Cholinergic activation of a population of corneal afferent nerves , 2004, Experimental Brain Research.